Malignant melanoma cells acquire the capacity to undergo transient and reversible morphological and functional changes by hijacking the embryonic neural crest invasion program, such that metastatic melanoma cells exploit neural crest-related receptor tyrosine kinases to increase plasticity and facilitate invasion, while primary melanocytes may actively suppress these responses under the same microenvironmental conditions [20]. This evidence concerns the gene NTRK1 and melanoma.